Jon R. Henriksen
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 22, 2026
Nationwide Real-World Outcomes of Trial Eligible and Trial Ineligible Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab.
Journal: Clinical genitourinary cancer
Published: April 09, 2025
Blood natural killer cells during treatment in recurrent ovarian cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 22, 2020
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy.
Journal: Journal of ovarian research
Published: January 16, 2020
Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 15, 2020
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer.
Journal: Translational oncology
Published: February 21, 2019
New Danish standardization of the Child Behaviour Checklist.
Journal: Danish medical journal
Published: July 05, 2012
Picture of the month: pseudohypoparathyroidism type II
Journal: Ugeskrift for laeger
Published: October 12, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026